NO940624L - Ekspressjonskonstruksjoner inneholdende HIV inhibitoriske antisens og andre nukleotidsekvenser, retrovirale vektorer og rekombinante retroviruser som inneholder disse - Google Patents

Ekspressjonskonstruksjoner inneholdende HIV inhibitoriske antisens og andre nukleotidsekvenser, retrovirale vektorer og rekombinante retroviruser som inneholder disse

Info

Publication number
NO940624L
NO940624L NO940624A NO940624A NO940624L NO 940624 L NO940624 L NO 940624L NO 940624 A NO940624 A NO 940624A NO 940624 A NO940624 A NO 940624A NO 940624 L NO940624 L NO 940624L
Authority
NO
Norway
Prior art keywords
nucleotide sequences
retroviral vectors
expression constructs
recombinant retroviruses
hiv inhibitory
Prior art date
Application number
NO940624A
Other languages
English (en)
Other versions
NO940624D0 (no
Inventor
Jagdeesh Pyati
Original Assignee
Ortho Pharmaseutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaseutical Corp filed Critical Ortho Pharmaseutical Corp
Publication of NO940624D0 publication Critical patent/NO940624D0/no
Publication of NO940624L publication Critical patent/NO940624L/no

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Behandling av sykdomstilstander, spesielt AIDS, gjennom administrering av antisens og andre nukleotld- konstruksjoner er beskrevet. Konstruksjonene blir administrert til pasienten på en tradisjonell farma- søytisk måte eller gjennom anvendelse av rekombinante retrovirusleveringssystemer. Sistnevnte leverings- systemer målsøker fortrinnsvis spesifikke celletyper eller andre komponenter som er ønskelig å målsøke. En slik målsøking blir oppnådd ved modifisering av kappen til et rekombinant produsert terapeutisk retrovirus for å oppnå ligand (reseptor) sekvenser som det eksisterer en reseptor (ligand) for på celletypen eller annen komponent.
NO940624A 1993-02-25 1994-02-24 Ekspressjonskonstruksjoner inneholdende HIV inhibitoriske antisens og andre nukleotidsekvenser, retrovirale vektorer og rekombinante retroviruser som inneholder disse NO940624L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2193693A 1993-02-25 1993-02-25

Publications (2)

Publication Number Publication Date
NO940624D0 NO940624D0 (no) 1994-02-24
NO940624L true NO940624L (no) 1994-08-26

Family

ID=21806956

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940624A NO940624L (no) 1993-02-25 1994-02-24 Ekspressjonskonstruksjoner inneholdende HIV inhibitoriske antisens og andre nukleotidsekvenser, retrovirale vektorer og rekombinante retroviruser som inneholder disse

Country Status (3)

Country Link
CA (1) CA2116253A1 (no)
NO (1) NO940624L (no)
ZA (1) ZA941287B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2726975T3 (es) * 2011-07-27 2019-10-11 Flash Therapeutics Método para la producción de partículas retrovíricas útiles para transducir células eucariotas

Also Published As

Publication number Publication date
NO940624D0 (no) 1994-02-24
ZA941287B (en) 1995-08-24
CA2116253A1 (en) 1994-08-26

Similar Documents

Publication Publication Date Title
Sarin et al. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone
US4880779A (en) Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus
DEVITA Jr et al. Developmental therapeutics and the acquired immunodeficiency syndrome
Sanchez et al. Treatment of cerebral aspergillosis with itraconazole: do high doses improve the prognosis?
KR20050055053A (ko) 만성 Ｃ형 간염을 치료하기 위한 폴리에틸렌글리콜-인터페론-α 및 리바비린의 용도
PL321791A1 (en) Method of and compositions and sets of agents for enhancing oral biological availability of pharmaceutic agents
Katlama et al. Individualized antiretroviral therapeutic approaches: less can be more
Asplen et al. Azathioprine therapy of steroid-responsive pericarditis
GR1002847B (el) Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
NO940624L (no) Ekspressjonskonstruksjoner inneholdende HIV inhibitoriske antisens og andre nukleotidsekvenser, retrovirale vektorer og rekombinante retroviruser som inneholder disse
Barbour The balance of risk and benefit in gene-therapy trials
Bahraoui et al. A molecular mechanism of inhibition of HIV-1 binding to CD4+ cells by monoclonal antibodies to gp110
EA200200801A1 (ru) Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия
SHIMIZU et al. Lignified materials as medicinal resources. VI. Anti-HIV activity of dehydrogenation polymer of p-coumaric acid, a synthetic lignin, in a quasi-in-vivo assay system as an intermediary step to clinical trials
Fujii et al. In vitro cytocidal effects of human immunodeficiency virus type 1 Nef on unprimed human CD4+ T cells without MHC restriction
Burzynski Toxicology studies on antineoplaston AS2-5 injections in cancer patients
AU5535498A (en) Treatment of HIV positive patients
Rochelle et al. Potentiation of antihypertensive therapy by use of chlorothiazide
JAVAHERIAN et al. V3-mediated heparin neutralization of HIV type 1
Okuda et al. New type of antibody-enzyme conjugate which specifically kills Candida albicans
Soheili et al. Larkin: FDA Emergency Use Authorized Treatment Protocol of DeltaRex-G for Severe Covid-19 [IND# 27185]
RU96116005A (ru) Штамм hominis immunodeficiti virus (hiv-i) вич-i/россия/гм-12-95 (ru1295) субтипа в для диагностических и вакцинных препаратов
Flexner New antiretroviral agents in clinical development
Habash et al. Supraventricular tachycardia of the sick: A unique entity
James T-20: entirely new antiretroviral